Petros Pharmaceuticals, Inc. Common Stock, Value, Issued
Petros Pharmaceuticals, Inc. (PTPI) had Common Stock, Value, Issued of $4.24 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $4.24K.
- 2026-03-31: Common Stock, Value, Issued $4.24K.
- 2025-12-31: Common Stock, Value, Issued $4.23K.
- 2025-09-30: Common Stock, Value, Issued $4.23K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $4.24K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.24K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $4.23K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.23K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $4.23K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $205.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $42.00 10-K · filed 2026-04-15 | $1.05K 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $930.00 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $688.00 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $298.00 10-K · filed 2025-03-31 | |
| 2023-09-30 | $211.00 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $211.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $209.00 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $208.00 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.07K 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | $2.07K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.07K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $207.00 10-K · filed 2023-03-31 | $2.07K 10-K · filed 2022-03-31 |
| 2021-09-30 | $983.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $983.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $980.00 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $971.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |